[
  {
    "ts": null,
    "headline": "Edwards Lifesciences Advances Structural Heart Care Through Innovation and Purpose",
    "summary": "IRVINE, Calif., February 26, 2026--At the close of Heart Month, Edwards Lifesciences (NYSE: EW) underscored its leadership in structural heart innovation, advancing care through deep expertise and strong partnerships so people with structural heart disease can live longer, healthier lives. As part of this commitment, Edwards announced the impact and renewed vision for Every Heartbeat Matters, its signature global health initiative, to help 2 million more patients facing barriers worldwide access",
    "url": "https://finnhub.io/api/news?id=313e434a678ddd22940d436901b9e693b22b76ba26fee2597a4ef8f58ccbaaeb",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1772115300,
      "headline": "Edwards Lifesciences Advances Structural Heart Care Through Innovation and Purpose",
      "id": 139235574,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "EW",
      "source": "Yahoo",
      "summary": "IRVINE, Calif., February 26, 2026--At the close of Heart Month, Edwards Lifesciences (NYSE: EW) underscored its leadership in structural heart innovation, advancing care through deep expertise and strong partnerships so people with structural heart disease can live longer, healthier lives. As part of this commitment, Edwards announced the impact and renewed vision for Every Heartbeat Matters, its signature global health initiative, to help 2 million more patients facing barriers worldwide access",
      "url": "https://finnhub.io/api/news?id=313e434a678ddd22940d436901b9e693b22b76ba26fee2597a4ef8f58ccbaaeb"
    }
  },
  {
    "ts": null,
    "headline": "10 Health Care Stocks Whale Activity In Today's Session",
    "summary": "",
    "url": "https://finnhub.io/api/news?id=cf0466e3c8cb3ff3ed9c2bfbb962deb01f43035da2b9ca0e4a6fff80fb1b0339",
    "source": "Benzinga",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1772112927,
      "headline": "10 Health Care Stocks Whale Activity In Today's Session",
      "id": 139247004,
      "image": "https://cdn.benzinga.com/files/images/story/2025/11/06/aggregated_options_3.jpg?width=2048&height=1536",
      "related": "EW",
      "source": "Benzinga",
      "summary": " ",
      "url": "https://finnhub.io/api/news?id=cf0466e3c8cb3ff3ed9c2bfbb962deb01f43035da2b9ca0e4a6fff80fb1b0339"
    }
  },
  {
    "ts": null,
    "headline": "Edwards Lifesciences Corporation (EW) Presents at Citi's 2026 Unplugged MedTech and Life Sciences Access Day Transcript",
    "summary": "Edwards Lifesciences Corporation (EW) Presents at Citi's 2026 Unplugged MedTech and Life Sciences Access Day Transcript",
    "url": "https://finnhub.io/api/news?id=74885183beb8c838c9ab12c4306e0e38dda337c4c0a2b779d0424c1174a6bacd",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1772112480,
      "headline": "Edwards Lifesciences Corporation (EW) Presents at Citi's 2026 Unplugged MedTech and Life Sciences Access Day Transcript",
      "id": 139237707,
      "image": "",
      "related": "EW",
      "source": "SeekingAlpha",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=74885183beb8c838c9ab12c4306e0e38dda337c4c0a2b779d0424c1174a6bacd"
    }
  },
  {
    "ts": null,
    "headline": "How The Edwards Lifesciences (EW) Investment Story Is Shifting After Mixed Analyst Revisions",
    "summary": "Edwards Lifesciences is working with a slightly lower fair value estimate, trimmed from US$97.11 to US$96.46 per share, which puts a finer point on how analysts are thinking about the stock today. That small shift lines up with a mix of optimism and caution in recent research, where some analysts are raising price targets while others are scaling them back in light of execution and competitive risks. As you read on, you will see how these moving targets fit into the broader story and what to...",
    "url": "https://finnhub.io/api/news?id=6eea965853bfd1cd233961c3ee2fd513c2fdf6461695dde55e0f56156ce4204c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1772104290,
      "headline": "How The Edwards Lifesciences (EW) Investment Story Is Shifting After Mixed Analyst Revisions",
      "id": 139231044,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "EW",
      "source": "Yahoo",
      "summary": "Edwards Lifesciences is working with a slightly lower fair value estimate, trimmed from US$97.11 to US$96.46 per share, which puts a finer point on how analysts are thinking about the stock today. That small shift lines up with a mix of optimism and caution in recent research, where some analysts are raising price targets while others are scaling them back in light of execution and competitive risks. As you read on, you will see how these moving targets fit into the broader story and what to...",
      "url": "https://finnhub.io/api/news?id=6eea965853bfd1cd233961c3ee2fd513c2fdf6461695dde55e0f56156ce4204c"
    }
  }
]